🇺🇸 FDA
Company

CATALYST

CATALYST PHARMACEUTICALS, INC.

CPRX pharma USA

Quick answer

CATALYST is a pharma company (CPRX) headquartered in CORAL GABLES, FL, USA with 23 tracked pipeline programs.

Pipeline (23)

project

Amifampridine Phosphate

Myasthenia Gravis, Generalized

Phase 3 · small_molecule · completed

1 trials project

Amifampridine Phosphate

Myasthenia Gravis, MuSK

Phase 3 · small_molecule · terminated

1 trials project

Amifampridine Phosphate

Lambert Eaton Myasthenic Syndrome

Phase 3 · small_molecule · completed

2 trials project

BT-001

Type2 Diabetes

Phase 3 · other · terminated

1 trials project

MarzAA

Hemophilia A With Inhibitor

Phase 3 · mab · terminated

1 trials project

amifampridine phosphate

Myasthenic Syndromes, Congenital

Phase 3 · small_molecule · completed

1 trials project

Amifampridine Phosphate

Muscular Atrophy, Spinal

Phase 2 · small_molecule · completed

1 trials project

Amifampridine Phosphate 10 MG Oral Tablet

Spinal Muscular Atrophy Type 3

Phase 2 · small_molecule · terminated

1 trials project

CPP-109 vigabatrin

Methamphetamine Dependence

Phase 2 · small_molecule · terminated

1 trials project

Coagulation Factor IX variant

Hemophilia B

Phase 2 · mab · completed

1 trials project

Coagulation Factor VIIa variant

Factor VII Deficiency

Phase 2 · mab · terminated

1 trials project

Coagulation Factor VIIa variant

Hemophilia A With Inhibitor

Phase 2 · mab · completed

1 trials project

Decitabine

Acute Myeloid Leukemia

Phase 2 · small_molecule · active

1 trials project

Dupilumab

COVID-19

Phase 2 · mab · completed

1 trials project

MHS-1031

Gastroesophageal Reflux

Phase 2 · small_molecule · active

1 trials project

vigabatrin

Cocaine Dependence

Phase 2 · small_molecule · completed

2 trials project

Airway Bypass

Emphysema or COPD

Phase 1 · other · active

1 trials project

Bumetanide

Seizures

Phase 1 · small_molecule · completed

1 trials project

CPP-115

Cocaine Dependency

Phase 1 · small_molecule · completed

1 trials project

HWK-016, MUCIN-16-targeted ADC

PROC

Phase 1 · small_molecule · active

1 trials project

ISU304/CB2679d/Dalcinonacog alfa 75~150 IU/kg

Hemophilia B

Phase 1 · mab · completed

1 trials project

MarzAA (marzeptacog alfa [activated])

Hemophilia A

Phase 1 · mab · completed

1 trials project

PF-05280602

Hemophilia A

Phase 1 · mab · completed

1 trials

Drugs (3)

drug

amifampridine phosphate

FIRDAPSE

 drug

perampanel

FYCOMPA

 drug

vamorolone

AGAMREE

Patents (8)

patent

US 11806421

Porous-cellulose particles and production method thereof, and cosmetic

Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11701307

Organic-inorganic composite particles, manufacturing method therefor, and cosmet

Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11491212

Subcutaneous administration of modified factor IX polypeptides and treatment of

Expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11401513

Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of us

Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11384062

Deuterated (S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide

Expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11266724

Modified factor VII polypeptides for subcutaneous administration and on-demand t

Expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11203749

Factor VII polypeptides that are modified and uses thereof

Expires Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11020326

Hollow particles and cosmetic

Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)